# ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI: 1/2 Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| Location | NEW YORK, NY |
| Project | 1/2 Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy |
| Project number | 1UG3HL185610-01 |
| Mechanism | UG3 |
| Institute | National Heart Lung and Blood Institute |
| Award | $946,567 |
| Awarded | 2026-09-08 |
| Project period | 2026-09-07 to 2027-08-31 |
| UEI | C8H9CNG1VBD9 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11349726). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.